__________________________________________________________________________________________________________________

Parcell Laboratories is a leading regenerative cell company that is positioned to change the face of medicine.  The company's platform technology, the ELA® cell, has unique structural properties to support and facilitate the regeneration of damaged tissues.  The cell is not embryonic, not controversial and  not expanded.  In addition, it does not invoke an immune response when implanted at sites of injury, thereby allowing it to be used for therapeutic doses in patients unrelated to the donor.

With age, the number of indigenous regenerative cells in the body declines and the healing process is at best slower or, at worst, incapable of healing a wound or defect.  Implanting ELA cells at a site of injury aids in the repair of tissues by directing a high concentration of structural cells to the injured site where they provide a framework to enhance the healing process. 

Parcell is dedicated to developing first-in-class cell-based therapeutics to facilitate the regeneration of damaged tissues throughout the body in order to improve the quality of life of patients of all ages. 

For more information about our technology, please contact us at                 617-928-9800 or info@parcelllabs.com.